Pre-Market
View all rates
Back to news
General

Minapharm Pharmaceuticals (MIPH.CA) - Auditor's Report

Published at 6 August 2026 at 09:08Minapharm PharmaceuticalsRelated stock:Minapharm Pharmaceuticals stockAll Minapharm Pharmaceuticals disclosures

Disclosure summary

Company Name : Minapharm Pharmaceuticals
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
With reference to the standalone financial statements for the financial period ended on 31/03/2026, attached is the limited review report of the standalone financial statements of Al-Mazzawi & Partners.

Auditor's Report (173 KB)